8-81283885-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001444.3(FABP5):āc.265T>Gā(p.Phe89Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 152,168 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001444.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FABP5 | NM_001444.3 | c.265T>G | p.Phe89Val | missense_variant | 3/4 | ENST00000297258.11 | NP_001435.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FABP5 | ENST00000297258.11 | c.265T>G | p.Phe89Val | missense_variant | 3/4 | 1 | NM_001444.3 | ENSP00000297258.6 | ||
FABP5 | ENST00000396359.1 | c.163T>G | p.Phe55Val | missense_variant | 3/4 | 5 | ENSP00000379647.1 | |||
FABP5 | ENST00000481695.1 | n.226T>G | non_coding_transcript_exon_variant | 2/2 | 2 | |||||
FABP5 | ENST00000486269.1 | n.524T>G | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152168Hom.: 0 Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 19, 2024 | The c.265T>G (p.F89V) alteration is located in exon 3 (coding exon 3) of the FABP5 gene. This alteration results from a T to G substitution at nucleotide position 265, causing the phenylalanine (F) at amino acid position 89 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at